IMNN

Imunon, Inc.

Imunon, Inc. (IMNN) has 22 SEC Form 4 filings (25 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 21, 2026.

The most active filer is General Counsel and Corp Sec Eylward Susan with 3 filings.

  • Industry:Biotechnology
  • CEO:Stacy R. Lindborg
  • Employees:25
  • HQ:Lawrenceville, NJ, US
  • IPO:1999-03-01

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$26K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$7.4M

latest known value

Source
Sale$4KJul 21SEC ↗
Sale$2KJul 7SEC ↗
Eylward SusanFirst filing
Sale$21KJun 29SEC ↗

Related companies

Imunon, Inc. is in the Healthcare sector.